Literature DB >> 17108760

Risk communication in completed series of breast cancer genetic counseling visits.

Arwen H Pieterse1, Sandra van Dulmen, Sandra van Dijk, Jozien M Bensing, Margreet G E M Ausems.   

Abstract

PURPOSE: There is no consensus on how best to communicate risk in breast cancer genetic counseling. We studied risk communication in completed series of counseling visits and assessed associations with counselees' postcounseling risk perception and satisfaction.
METHODS: Pre- and postcounseling questionnaires and videorecordings of all visits were available for 51 affected and unaffected women from families with no known BRCA1/2 mutation, who fulfilled criteria for DNA testing. We developed a checklist for assessing risk communication and counselors' behaviors.
RESULTS: General risks were mainly communicated in initial visits, while counselee-specific risks were discussed mainly in concluding visits. The risks discussed most often were conveyed only numerically or qualitatively, and most were only stated positively or negatively. Counselors regularly helped counselees to understand the information, but seldom built on counselees' pre-existing perspective. Counselees' breast cancer risk perception after counseling was unrelated to whether this risk had been explicitly stated. The number of general risks discussed was negatively associated with counselees' satisfaction about counseling.
CONCLUSION: Findings suggest that counselors' authority prevails over mutuality with individual counselees, in their communication about risks.

Entities:  

Mesh:

Year:  2006        PMID: 17108760     DOI: 10.1097/01.gim.0000245579.79093.86

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  9 in total

1.  A focus group study on breast cancer risk presentation: one format does not fit all.

Authors:  Michel Dorval; Karine Bouchard; Jocelyne Chiquette; Gord Glendon; Christine M Maugard; Wilhelm Dubuisson; Seema Panchal; Jacques Simard
Journal:  Eur J Hum Genet       Date:  2012-11-21       Impact factor: 4.246

2.  Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.

Authors:  Fabrice Kwiatkowski; Pascal Dessenne; Claire Laquet; Marie-Françoise Petit; Yves-Jean Bignon
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

3.  Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.

Authors:  Susanne B Haga; Rachel Mills; Kathryn I Pollak; Catherine Rehder; Adam H Buchanan; Isaac M Lipkus; Jennifer H Crow; Michael Datto
Journal:  Genome Med       Date:  2014-07-31       Impact factor: 11.117

Review 4.  Communication about genetic testing with breast and ovarian cancer patients: a scoping review.

Authors:  Chris Jacobs; Christine Patch; Susan Michie
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

5.  Do Preferred Risk Formats Lead to Better Understanding? A Multicenter Controlled Trial on Communicating Familial Breast Cancer Risks Using Different Risk Formats.

Authors:  Lidewij Henneman; Christi J van Asperen; Jan C Oosterwijk; Fred H Menko; Liesbeth Claassen; Daniëlle Rm Timmermans
Journal:  Patient Prefer Adherence       Date:  2020-02-19       Impact factor: 2.711

6.  Head to head randomized trial of two decision aids for prostate cancer.

Authors:  Angela Fagerlin; Margaret Holmes-Rovner; Timothy P Hofer; David Rovner; Stewart C Alexander; Sara J Knight; Bruce S Ling; James A Tulsky; John T Wei; Khaled Hafez; Valerie C Kahn; Daniel Connochie; Jeffery Gingrich; Peter A Ubel
Journal:  BMC Med Inform Decis Mak       Date:  2021-05-12       Impact factor: 2.796

7.  Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling.

Authors:  Caroline F Ockhuysen-Vermey; Lidewij Henneman; Christi J van Asperen; Jan C Oosterwijk; Fred H Menko; Daniëlle R M Timmermans
Journal:  BMC Cancer       Date:  2008-10-03       Impact factor: 4.430

8.  Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.

Authors:  Akke Albada; Sandra van Dulmen; Henrietta Dijkstra; Ivette Wieffer; Arjen Witkamp; Margreet G E M Ausems
Journal:  J Genet Couns       Date:  2015-09-01       Impact factor: 2.537

Review 9.  A systematic review of the impact of genetic counseling on risk perception accuracy.

Authors:  Chris M R Smerecnik; Ilse Mesters; Eline Verweij; Nanne K de Vries; Hein de Vries
Journal:  J Genet Couns       Date:  2009-03-17       Impact factor: 2.537

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.